David Mulham Mulham net worth and biography

David Mulham Biography and Net Worth

Insider of USANA Health Sciences

David Mulham is Chief Field Development Officer of the Company. Mr. Mulham joined USANA in 2009 as Field Development, Marketing and Customer Service Manager for Australia and New Zealand. In February 2011, he was appointed General Manager, for Australia and New Zealand and served in that role until June 2011, when he was appointed Vice President, Pacific Region (Australia, New Zealand and Philippines). In February 2014 he was appointed Executive Vice President of Field Development, Pacific Region and then in May 2015 he was appointed Executive Vice President, Pacific Region. He served in that role until January 2016 when he was appointed Executive Vice President, Pacific and Europe and then in September 2016, he was appointed Executive Vice President, the Americas, Pacific and Europe. He served in that position until February 2017, when he was appointed Chief Field Development Officer. Prior to joining USANA, Mr. Mulham had extensive experience in the direct selling industry working for Amway, Mary Kay, Nutri Metics and Dorling Kindersley Family Learning. He subsequently worked in property development as Director of both Hunter Valley Gardens and Tempus Two Winery. Mr. Mulham has a post graduate diploma from Macquarie Graduate School of Management, Sydney, and received the Silver Stevie Award in 2015, for Executive of the Year – Health Products & Services and Pharmaceuticals.

What is David Mulham Mulham's net worth?: The estimated net worth of David Mulham Mulham is at least $312,217.50 as of February 29th, 2024. Mr. Mulham owns 7,825 shares of USANA Health Sciences stock worth more than $312,218 as of November 23rd. This net worth evaluation does not reflect any other assets that Mr. Mulham may own. Learn More about David Mulham Mulham's net worth.
How do I contact David Mulham Mulham?: The corporate mailing address for Mr. Mulham and other USANA Health Sciences executives is 3838 West Parkway Blvd, Salt Lake City UT, 84120. USANA Health Sciences can also be reached via phone at (801) 954-7100 and via email at [email protected]. Learn More on David Mulham Mulham's contact information.
Has David Mulham Mulham been buying or selling shares of USANA Health Sciences?: David Mulham Mulham has not been actively trading shares of USANA Health Sciences during the past quarter. Most recently, David Mulham Mulham sold 4,311 shares of the business's stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $47.76, for a transaction totalling $205,893.36. Following the completion of the sale, the insider now directly owns 7,825 shares of the company's stock, valued at $373,722. Learn More on David Mulham Mulham's trading history.
Who are USANA Health Sciences' active insiders?: USANA Health Sciences' insider roster includes Robert Auciaux (Director), Jim Brown (President), John Fleming (Director), Joshua Foukas (Insider), Gilbert Fuller (Director), G. Iiekking (CFO), Daniel Macuga (Insider), David Mulham (Insider), Brent Neidig (Insider), Walter Noot (COO), Feng Peng (Director), Robert Sinnott (Insider), Myron Wentz (Major Shareholder), and Frederic Winssinger (Director). Learn More on USANA Health Sciences' active insiders.
Are insiders buying or selling shares of USANA Health Sciences?: In the last twelve months, insiders at the sold shares 17 times. They sold a total of 65,325 shares worth more than $3,011,529.28. The most recent insider tranaction occured on November, 4th when Director Gilbert A. Fuller sold 675 shares worth more than $25,454.25. Insiders at USANA Health Sciences own 0.3% of the company. Learn More about insider trades at USANA Health Sciences.
Information on this page was last updated on 11/4/2024.

David Mulham Mulham Insider Trading History at USANA Health Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/29/2024	Sell	4,311	$47.76	$205,893.36	7,825
8/15/2023	Sell	2,159	$65.34	$141,069.06	5,448
8/11/2023	Sell	1,080	$66.28	$71,582.40	7,607
7/31/2023	Sell	3,354	$65.00	$218,010.00	8,687
4/28/2023	Sell	1,138	$67.40	$76,701.20	13,598
11/15/2021	Sell	569	$102.00	$58,038.00
11/3/2021	Sell	1,277	$99.63	$127,227.51
3/1/2021	Sell	639	$99.00	$63,261.00	9,309
2/18/2021	Sell	3,145	$91.00	$286,195.00	11,453
5/16/2018	Sell	14,733	$113.03	$1,665,270.99	14,733

David Mulham Mulham Buying and Selling Activity at USANA Health Sciences

USANA Health Sciences Company Overview

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $39.90

$39.50

$40.22

50 Day Range

MA: $37.80

$34.50

$41.29

2 Week Range

Now: $39.90

$34.15

$54.81

Volume

83,194 shs

Average Volume

81,034 shs

Market Capitalization

$760.49 million

P/E Ratio

14.10

Dividend Yield

N/A

Beta

0.89

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW